Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients
Malagola, Michele, Skert, Cristina, Borlenghi, Erika, Chiarini, Marco, Cattaneo, Chiara, Morello, Enrico, Cancelli, Valeria, Cattina, Federica, Cerqui, Elisa, Pagani, Chiara, Passi, Angela, Ribolla, RVolume:
5
Language:
english
Journal:
Cancer Medicine
DOI:
10.1002/cam4.593
Date:
February, 2016
File:
PDF, 120 KB
english, 2016